Cogent Biosciences (COGT) Shares Outstanding (2017 - 2026)
Cogent Biosciences (COGT) posted quarterly Shares Outstanding (Entity) of $170.8 million for Q1 2026, up 49.99% year-over-year from $113.9 million in Q1 2025, and up 32.49% quarter-over-quarter from $128.9 million in Q4 2025.
Cogent Biosciences (COGT) Shares Outstanding (2017 - 2026) Analysis & Trends
Cogent Biosciences (COGT) has reported Shares Outstanding (Entity) for 10 consecutive years, with $170.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 49.99% year-over-year to $170.8 million; the TTM figure through Mar 2026 stood at $170.8 million (up 49.99% YoY), while the FY2025 annual figure was $128.9 million, up 16.69% from the prior year.
- Shares Outstanding (Entity) advanced to $170.8 million in Q1 2026 per COGT's latest filing, from $128.9 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $170.8 million in Q1 2026 and bottomed at $45.8 million in Q1 2022.
- Historically, Shares Outstanding (Entity) has averaged $97.5 million across 5 years, with a median of $95.6 million in 2024.
- Annual changes were most pronounced in 2022 — Shares Outstanding (Entity) jumped 75.3% — and 2025, when it increased 4.19%.
- Cogent Biosciences' Shares Outstanding (Entity) stood at $69.9 million in 2022, then increased by 23.22% to $86.1 million in 2023, then grew by 28.26% to $110.5 million in 2024, then increased by 16.69% to $128.9 million in 2025, then jumped by 32.49% to $170.8 million in 2026.
- Business Quant data shows COGT's Shares Outstanding (Entity) at $170.8 million in Q1 2026, $128.9 million in Q4 2025, and $139.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 253.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 102.80 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 62.19 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.45 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 445.06 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 133.61 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Cogent Biosciences | 6.58 Bn | 6.58 Bn | - | 171.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 171.01 Mn |
| Mar 31, 2026 | 162.19 Mn |
| Dec 31, 2025 | 128.90 Mn |
| Sep 30, 2025 | 137.55 Mn |
| Jun 30, 2025 | 114.47 Mn |
| Mar 31, 2025 | 113.31 Mn |
| Dec 31, 2024 | 103.86 Mn |
| Sep 30, 2024 | 110.17 Mn |
| Jun 30, 2024 | 99.24 Mn |
| Mar 31, 2024 | 94.80 Mn |
| Dec 31, 2023 | 79.66 Mn |
| Sep 30, 2023 | 86.17 Mn |
| Jun 30, 2023 | 74.75 Mn |
| Mar 31, 2023 | 70.73 Mn |
| Dec 31, 2022 | 58.74 Mn |
| Sep 30, 2022 | 69.58 Mn |
| Jun 30, 2022 | 49.39 Mn |
| Mar 31, 2022 | 45.11 Mn |
| Dec 31, 2021 | 38.73 Mn |
| Sep 30, 2021 | 39.85 Mn |